These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23452867)

  • 21. Oxycontin--misuse and abuse.
    Suleman R; Abourjaily H; Rosenberg M
    J Mass Dent Soc; 2002; 51(2):56-8. PubMed ID: 12108125
    [No Abstract]   [Full Text] [Related]  

  • 22. The controversy surrounding OxyContin abuse: issues and solutions.
    Jayawant SS; Balkrishnan R
    Ther Clin Risk Manag; 2005 Jun; 1(2):77-82. PubMed ID: 18360547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OxyContin abuse and diversion and efforts to address the problem: highlights of a government report.
    Government Accounting Office
    J Pain Palliat Care Pharmacother; 2004; 18(3):109-13. PubMed ID: 15364638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. State medical board members' beliefs about pain, addiction, and diversion and abuse: a changing regulatory environment.
    Gilson AM; Maurer MA; Joranson DE
    J Pain; 2007 Sep; 8(9):682-91. PubMed ID: 17627894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Codeine and oxycodone use in patients with chronic rheumatic disease pain.
    Ytterberg SR; Mahowald ML; Woods SR
    Arthritis Rheum; 1998 Sep; 41(9):1603-12. PubMed ID: 9751092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe postherpetic neuralgia pain.
    Fan BF;
    Oncology; 2008; 74 Suppl 1():66-71. PubMed ID: 18758201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-medical use of OxyContin Tablets in the United States.
    Sees KL; Di Marino ME; Ruediger NK; Sweeney CT; Shiffman S
    J Pain Palliat Care Pharmacother; 2005; 19(2):13-23. PubMed ID: 16061457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioequivalence of oxycodone hydrochoride extended release tablets to marketed reference products OxyContin® in Canada and US.
    Gosai P; Ducharme MP; Godfrey AR; Freeman JC; Monif T; Kumar KS; Kumar S; Mudnaik R; Katikaneni P
    Int J Clin Pharmacol Ther; 2013 Nov; 51(11):895-907. PubMed ID: 23673291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OxyContin misuse on a reservation: qualitative reports by American Indians in talking circles.
    Momper SL; Delva J; Reed BG
    Subst Use Misuse; 2011; 46(11):1372-9. PubMed ID: 21810072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe cancer pain.
    Yu SY;
    Oncology; 2008; 74 Suppl 1():46-51. PubMed ID: 18758197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxycodone and oxycontin.
    Med Lett Drugs Ther; 2001 Sep; 43(1113):80-1. PubMed ID: 11581580
    [No Abstract]   [Full Text] [Related]  

  • 33. Criminal law: physician convicted for recklessly prescribing OxyContin.
    Romanow K
    J Law Med Ethics; 2003; 31(1):154-5. PubMed ID: 12762109
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical considerations in the treatment of chronic pain with opiates.
    Naliboff BD; Wu SM; Pham Q
    J Clin Psychol; 2006 Nov; 62(11):1397-408. PubMed ID: 16937352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Internet-based survey of nonmedical prescription opioid use in the United States.
    Katz N; Fernandez K; Chang A; Benoit C; Butler SF
    Clin J Pain; 2008; 24(6):528-35. PubMed ID: 18574362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlations of cancer pain degree with levels of β-EP, CGRP and PGE2 and the effects of oxycontin on them.
    Chong D; Shao L; Yang Y; Wang R; Yang C; Zhang B
    J BUON; 2018; 23(5):1552-1557. PubMed ID: 30570885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of controlled-release oxycodone and standard therapies for postoperative pain after knee or hip replacement.
    de Beer Jde V; Winemaker MJ; Donnelly GA; Miceli PC; Reiz JL; Harsanyi Z; Payne LW; Darke AC
    Can J Surg; 2005 Aug; 48(4):277-83. PubMed ID: 16149361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How can a methadone and an opiate-positive immunoassay result be reconciled in a patient prescribed only OxyContin and Wellbutrin?
    Abadie JM
    Ann Clin Lab Sci; 2013; 43(2):190-4. PubMed ID: 23694796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. States respond to growing abuse of painkiller.
    Wasserman S
    State Legis; 2001; 27(9):33-4. PubMed ID: 11763873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OxyContin abuse: who are the users?
    Rawson RA; Maxwell J; Rutkowski B
    Am J Psychiatry; 2007 Nov; 164(11):1634-6. PubMed ID: 17974924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.